References
- Saito Y, Schoenfeld P, Locke GR. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97:1910.
- Drossman DA, Corazziari E, Talley NJ, Whitehead WE, Rome II. The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: a multinational concensus. 2nd ed. McLean VA: Degnon Associates; 2000.
- Boyce PM, Koloski NA, Talley NJL. Irritable bowel syndrome according to varying diagnostic criteria; are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000;95:3176.
- Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, An evidence based systematic review on the management of irritable bowel syndrome american college of gastroenterology task force on ibs. Am J Gastroenterol 2009;S1–35.
- Habba SF. Diarrhea predominant irritable bowel syndrome(ibs-d):fact or fiction. Medical Hypotheses 2011;76:97–9.
- Habba SF. Chronic diarrhea:identifying a new syndrome. Am J Gastroenterol 2002;8:2140–41.
- Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011;364:22.